Idarubicin hydrochloride is an anti mitotic and cytotoxic agent. It is used for the first-line treatment of adult acute non lymphocytic leukemia (ANLL) and induction of remission in relapsed and refractory patients. As a second-line treatment, drugs are used for acute lymphoblastic leukemia (all) in adults and children.